title: Considerable use of furazolidone in Iran.
authors.forename: Amin Talebi Bezmin
authors.initials: AT
authors.lastname: Abadi
authors.forename: Tarang
authors.initials: T
authors.lastname: Taghvaei
authors.forename: Dino
authors.initials: D
authors.lastname: Vaira
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage; D000863:Antacids / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005664:Furazolidone / Q000008:administration & dosage*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D007492:Iran; D009853:Omeprazole / Q000008:administration & dosage; D009942:Organometallic Compounds / Q000008:administration & dosage
chemical_list: D000863:Antacids; D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D005664:Furazolidone; D000658:Amoxicillin; C002791:bismuth tripotassium dicitrate; D009853:Omeprazole